Mersana Therapeutics Inc.
(MRSN)
undefined
undefined%
At close: undefined
2.15
0.23%
After-hours Dec 13, 2024, 05:51 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Revenue | 36.85M | 26.58M | 43.00K | 828.00K | 42.12M | 10.59M | 17.55M | 25.17M | 10.36M |
Cost of Revenue | 148.27M | 927.00K | 132.01M | 67.04M | 55.04M | 59.91M | 928.00K | 32.01M | 21.35M |
Gross Profit | -111.41M | 25.65M | -131.97M | -66.21M | -12.92M | -49.32M | 16.62M | -6.84M | -10.99M |
Operating Income | -170.96M | -204.69M | -169.71M | -87.69M | -29.22M | -65.66M | -39.62M | -13.82M | -16.34M |
Interest Income | 12.07M | 2.88M | 65.00K | 424.00K | 2.23M | 1.40M | 910.00K | 121.00K | 2.00K |
Pretax Income | -171.67M | -204.21M | -170.06M | -88.05M | -28.21M | -64.26M | -38.71M | -13.70M | -16.43M |
Net Income | -171.67M | -207.54M | -169.21M | -88.40M | -27.20M | -64.26M | -38.71M | -13.70M | -16.43M |
Selling & General & Admin | 59.54M | 56.96M | 36.89M | 21.90M | 17.28M | 16.33M | 10.46M | 6.98M | 5.35M |
Research & Development | 148.27M | 173.38M | 132.01M | 67.04M | 55.04M | 59.91M | 46.70M | 32.01M | 21.35M |
Other Expenses | - | -445.00K | -1.20M | - | - | 1.40M | - | - | -89.00K |
Operating Expenses | 36.85M | 230.35M | 168.90M | 88.94M | 72.32M | 76.25M | 57.16M | 38.99M | 26.70M |
Interest Expense | 4.07M | 3.33M | 1.27M | 359.00K | 234.00K | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 207.81M | 230.35M | 168.90M | 88.94M | 72.32M | 76.25M | 57.16M | 38.99M | 26.70M |
Income Tax | - | 3.33M | -855.00K | 359.00K | -1.01M | 1.40M | - | - | -2.00K |
Shares Outstanding (Basic) | 116.11M | 93.65M | 70.58M | 61.49M | 43.40M | 23.03M | 12.02M | 17.49M | 17.49M |
Shares Outstanding (Diluted) | 116.11M | 93.65M | 70.58M | 61.49M | 43.49M | 23.03M | 12.02M | 17.49M | 17.49M |
EPS (Basic) | -1.48 | -2.22 | -2.4 | -1.44 | -0.63 | -2.79 | -3.22 | -0.78 | -0.94 |
EPS (Diluted) | -1.48 | -2.22 | -2.4 | -1.44 | -0.63 | -2.79 | -3.22 | -0.78 | -0.94 |
EBITDA | -166.08M | -199.96M | -167.94M | -86.68M | -26.73M | -63.00M | -37.78M | -13.17M | -16.04M |
Depreciation & Amortization | 1.52M | 927.00K | 855.00K | 1.01M | 1.25M | 1.26M | 928.00K | 655.00K | 297.00K |